|
|
Substance Name: Glipizide [USAN:USP:INN:BAN]
RN: 29094-61-9
UNII: X7WDT95N5C
InChIKey: ZJJXGWJIGJFDTL-UHFFFAOYSA-N
Note
- An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
Molecular Formula
- C21-H27-N5-O4-S
Molecular Weight
- 445.5413
- All
- Classifications
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Toxicity
- Physical Properties
Classification Codes
- Antidiabetic
- Antiviral (COVID-19)
- Drug / Therapeutic Agent
- Human Data
- Hypoglycemic Agents
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Glipizide
- Glipizide [USAN:USP:INN:BAN]
MeSH Heading
- Glipizide
Synonyms
- 1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea
- Aldiab
- Apamid
- BRN 0903495
- CP 28,720
- CP 28720
- CP-28,720
- Digrin
- Dipazide
- EINECS 249-427-6
- Glibenese
- Glibetin
- Glican
- Glide
- Glidiab
- Glipid
- Glipizida
- Glipizida [INN-Spanish]
- Glipizide
- Glipizidum
- Glipizidum [INN-Latin]
- Gluco-Rite
- Glucolip
- Glucotrol
- Glucotrol XL
- Glucozide
- Glupitel
- Glupizide
- Glyde
- Glydiazinamide
- K 4024
- Melizide
- Mindiab
- Minidab
- Minidiab
- Minodiab
- N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
- Napizide
- NSC 759120
- Ozidia
- Pyrazinecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-
- Sucrazide
- TK 1320
- UNII-X7WDT95N5C
Systematic Names
- Glipizide
- Pyrazinecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-
- Urea, 1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)-
Mixture Name
- Metaglip
Registry Numbers
CAS Registry Number
- 29094-61-9
FDA UNII
- X7WDT95N5C
Other Registry Numbers
- 172964-66-8
- 29094-66-4
- 38777-27-4
System Generated Number
- 0029094619
Structure Descriptors
InChI
InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)InChIKey
ZJJXGWJIGJFDTL-UHFFFAOYSA-NSmiles
Cc1cnc(cn1)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
child | TDLo | oral | 379ug/kg (0.379mg/kg) | ENDOCRINE: HYPOGLYCEMIA | Annals of Emergency Medicine. Vol. 31, Pg. 773, 1998. |
guinea pig | LD50 | intraperitoneal | 2400mg/kg (2400mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 208, 1971. | |
guinea pig | LDLo | oral | > 4gm/kg (4000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 208, 1971. | |
mouse | LD50 | intraperitoneal | > 3gm/kg (3000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 208, 1971. | |
mouse | LDLo | oral | > 4gm/kg (4000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 208, 1971. | |
rat | LD50 | intraperitoneal | 1200mg/kg (1200mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 208, 1971. | |
rat | LDLo | oral | > 4gm/kg (4000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 21, Pg. 208, 1971. |
Physical Properties
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
pKa Dissociation Constant | 5.9 | (none) | EXP | |
log P (octanol-water) | 1.91 | (none) | EXP | |
Water Solubility | 37.2 | mg/L | 25 | EST |
Vapor Pressure | 2.73E-16 | mm Hg | 25 | EST |
Henry's Law Constant | 1.03E-20 | atm-m3/mole | 25 | EST |
Atmospheric OH Rate Constant | 3.42E-11 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.